Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Depth of response from fixed-duration treatment (i.e. major response at 6 months) is associated with superior survival (PFS and OS) in Waldenstrom macroglobulinemia.”
Authors: Jonas Paludo, Jithma Abeykoon, Nirosha Perera, Shayna Sarosiek, Joshua Gustine, Morie Gertz, Susan Geyer, Steven Treon, Jorge Castillo, Stephen Ansell et al.
More posts featuring Robert Orlowski.